Morgan Stanley Inozyme Pharma, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Morgan Stanley holds 158,846 shares of INZY stock, worth $317,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,846

Previous 78,898 101.33%

Holding current value

$317,692

Previous $351,000 136.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.31 - $6.0 $344,575 - $479,688	79,948 Added 101.33%	158,846 $830,000
Q2 2024 Oct 17, 2024	SELL	$4.33 - $7.31 $196,356 - $331,493	-45,348 Reduced 36.5%	78,898 $351,000
Q2 2024 Aug 14, 2024	SELL	$4.33 - $7.31 $196,356 - $331,493	-45,348 Reduced 36.5%	78,898 $351,000
Q1 2024 Oct 17, 2024	BUY	$4.14 - $7.66 $187,740 - $347,365	45,348 Added 57.48%	124,246 $951,000
Q1 2024 Aug 16, 2024	BUY	$4.14 - $7.66 $36,291 - $67,147	8,766 Added 7.59%	124,246 $951,000
Q1 2024 May 15, 2024	BUY	$4.14 - $7.66 $36,291 - $67,147	8,766 Added 7.59%	124,246 $951,000
Q4 2023 Aug 16, 2024	BUY	$2.71 - $4.5 $99,137 - $164,619	36,582 Added 46.37%	115,480 $491,000
Q4 2023 Feb 13, 2024	BUY	$2.71 - $4.5 $241,482 - $400,986	89,108 Added 337.89%	115,480 $491,000
Q3 2023 Nov 15, 2023	SELL	$4.09 - $7.0 $29,501 - $50,491	-7,213 Reduced 21.48%	26,372 $110,000
Q2 2023 Aug 14, 2023	BUY	$4.93 - $6.74 $70,148 - $95,903	14,229 Added 73.51%	33,585 $187,000
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $8,073 - $35,583	6,210 Added 47.24%	19,356 $110,000
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.82 $9,594 - $25,769	-9,138 Reduced 41.01%	13,146 $13,000
Q3 2022 Nov 14, 2022	SELL	$2.57 - $5.45 $48,547 - $102,950	-18,890 Reduced 45.88%	22,284 $59,000
Q2 2022 Oct 27, 2022	BUY	$3.2 - $5.96 $80,758 - $150,412	25,237 Added 158.35%	41,174 $197,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.96 $80,758 - $150,412	25,237 Added 158.35%	41,174 $197,000
Q1 2022 Oct 27, 2022	SELL	$3.87 - $7.55 $97,667 - $190,539	-25,237 Reduced 61.29%	15,937 $64,000
Q1 2022 May 13, 2022	SELL	$3.87 - $7.55 $13,556 - $26,447	-3,503 Reduced 18.02%	15,937 $64,000
Q4 2021 Feb 14, 2022	BUY	$5.58 - $11.5 $8,068 - $16,629	1,446 Added 8.04%	19,440 $133,000
Q3 2021 Nov 15, 2021	BUY	$11.12 - $19.4 $200,093 - $349,083	17,994 New	17,994 $209,000

Others Institutions Holding INZY

# of Institutions

Shares Held

53M

Call Options Held

3.7K

Put Options Held

5.8K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $80.3M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account